Cardinal Health (NYSE:CAH) (NYSE: CAH) is a diversified health care services and products company that provides pharmaceuticals and medical products to a broad range of customers, including hospitals, health systems, pharmacies and ambulatory surgery centers. Founded in 1971 and headquartered in Dublin, Ohio, the company has grown through strategic acquisitions and organic expansion to become one of the largest global distributors of generic pharmaceuticals and medical-surgical supplies.
The company’s operations are organized into two primary segments: Pharmaceutical and Medical. In its Pharmaceutical segment, Cardinal Health distributes branded and generic drugs, over-the-counter products and specialty pharmaceuticals. The Medical segment offers a wide array of products such as surgical gloves, exam gloves, fluid management products, infection prevention solutions and clinical nutrition supplies. Both segments are supported by value-added services, including supply chain analytics, inventory management, pharmacy automation and consulting services designed to optimize operational efficiency for health care providers.
With operations in more than 45 countries, Cardinal Health maintains a vast logistics network of distribution centers, hubs and cross-dock facilities, enabling timely delivery of critical products. The company also partners with manufacturers, group purchasing organizations and government entities to enhance access to medicines and medical supplies in both mature and emerging markets. In recent years, it has expanded its presence in Asia, Europe and Latin America, while investing in digital platforms to support e-commerce and data-driven decision-making across its customer base.
Leadership at Cardinal Health is led by President and Chief Executive Officer Mike Kaufmann, who assumed the role in April 2022. Under his guidance, the company has prioritized operational excellence, quality assurance and sustainability initiatives. The executive team continues to focus on innovation in supply chain solutions and expanding specialty drug services to address evolving needs in patient care and health care delivery systems worldwide.
